Investment
Features
FeesSafety
Academy
More
Pluang+

Markets cautious as dollar, bond yields hold firm; Bitcoin dips below $83K, gold near $4,180

Market News
12 Oct 2026
Coindesk
View Source
Neutral
Markets cautious as dollar, bond yields hold firm; Bitcoin dips below $83K, gold near $4,180

Markets opened cautiously with the U.S. dollar and bond yields remaining strong. Bitcoin trades just above $83,000, down about 0.5%, while gold hovers around $4,180 an ounce, also down roughly 0.5%. Tech futures slipped slightly, and crude oil prices edged higher above $92 a barrel. Bond yields rose as prices fell after a brief rebound last week. Investors are focused on Wednesday's U.S. inflation report, which is expected to show a rise in core inflation to 2.5% and headline inflation to 3.7%, signaling a possible inflation uptick. Additionally, IREN, a company shifting from bitcoin mining to AI infrastructure, gained 4% pre-market after securing a multiyear cloud services deal with AI firm Anthropic.

Markets struggling for momentum provide context for Pluang's crypto market data. For readers following cryptocurrencies, here is Pluang's market snapshot as of Oct 12, 2026 17:41 WIB: 37 of 50 major cryptocurrencies rose today. Notable movers include LINK at Rp238.909 with a 1-day change of +3.78% and a typical hold time of 63 days, SNX at Rp4.466 with a 1-day change of +3.74% and 100% sell order activity, and SUSHI at Rp4.338 with a 1-day change of +3.54% and 70% buy order activity.

More News

Harmony Biosciences appoints Peter Anastasiou as new CEO starting January 2027, with current CEO retiring.

Harmony Biosciences appoints Peter Anastasiou as new CEO starting January 2027, with current CEO retiring.

Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the com...

Company Fundamentals
Bullish
34 minutes ago
Obexelimab shows sustained benefits in IgG4-related disease, reducing steroid toxicity and supporting vaccine response.

Obexelimab shows sustained benefits in IgG4-related disease, reducing steroid toxicity and supporting vaccine response.

Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patien...

Market News
Bullish
34 minutes ago
St. Louis Blues to air 10 Thursday games on Gray Media's ABC 32 in 2026-27 season

St. Louis Blues to air 10 Thursday games on Gray Media's ABC 32 in 2026-27 season

The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...

Market News
Bullish
34 minutes ago
Fate Therapeutics appoints Jamie Harrell to lead commercialization of CAR T-cell therapies for autoimmune diseases.

Fate Therapeutics appoints Jamie Harrell to lead commercialization of CAR T-cell therapies for autoimmune diseases.

Fate Therapeutics has appointed Jamie Harrell as Senior Vice President of Market Development & Commercial Operations to spearhead the commercialization of its CAR T-cell therapies, including FT819 and FT839, targeting autoimmune diseases like lupus n...

Market News
Bullish
34 minutes ago
Study shows MicroPulse laser therapy cuts eye pressure and meds in glaucoma patients over 2 years

Study shows MicroPulse laser therapy cuts eye pressure and meds in glaucoma patients over 2 years

Iridex Corporation announced a two-year clinical study demonstrating that MicroPulse transscleral laser therapy significantly reduces intraocular pressure (IOP) and medication use in patients with early to advanced glaucoma. The study, involving 84 e...

Market News
Bullish
34 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App